Article Details

California Biotech. Reports Positive Phase 3 Results

Retrieved on: 2024-06-25 19:05:54

Tags for this article:

Click the tags to see associated articles and topics

California Biotech. Reports Positive Phase 3 Results. View article details on hiswai:

Excerpt

The analysts reaffirmed their Buy rating and US$4.50 price target on the stock. "We are highly confident that OLC data to date represent an approvable ...

Article found on: www.streetwisereports.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo